4D Molecular Therapeutics
Manufacturing · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
5858 Horton St Ste 455, Emeryville, Cali...Phone Number
(510) 505-2680Revenue
$88.2 MillionStock Symbol
FDMTIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About 4D Molecular Therapeutics
4D Molecular Therapeutics (4DMT) is a clinical-stage biopharmaceutical company focused on inventing and developing innovative products to unlock the full potential of genetic medicine for the treatment of large-market diseases. The company utilizes its proprietary vector discovery platform, Therapeutic Vector Evolution, to engineer customized gene delivery vehicles (vectors) designed to deliver therapeutic payloads to specific tissue types affected by disease, using the optimal route of administration. 4DMTs integrated product design, development, and manufacturing engine enables efficient creation of a diverse and valuable product pipeline. Through a combination of bold innovation and disciplined execution, the company aims to revolutionize the field of genetic medicine and pursue potentially curative therapies.Explore more
4D Molecular Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is 4D Molecular Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at 4D Molecular Therapeutics
Funding: Get notified immidiatlly once 4D Molecular Therapeutics has new funding data
Product Launch: Get notified when 4D Molecular Therapeutics launches new products
Click to see if 4D Molecular Therapeutics had a recent Job posting/layoffs
Earning: See what the market has to say on 4D Molecular Therapeutics recently announced quarterly report
Website visits: Recent activity has been detected on your website
Check if 4D Molecular Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Check out if 4D Molecular Therapeutics is spiking on competitors!
4D Molecular Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at 4D Molecular Therapeutics
Find more new buyers
Compare Similar Companies to 4D Molecular Therapeutics
Compare insights from companies similar to 4D Molecular Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
4D Molecular Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
4D Molecular Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about 4D Molecular Therapeutics.
4D Molecular Therapeutics financials insights
Gather financial insights about 4D Molecular Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2017
Series A
$14.6M
2018
Series B
$90M
2019
Stock Offering
$100M
2020
Series C
$75M
Stock Offering
$193M
4D Molecular Therapeutics Tech Stack
A closer look at the technologies used by 4D Molecular Therapeutics
See more technologies
Most Recent Scoops
Open Position
Open Position
Open Position
Person-Based
Stake & Stock Ownership, Finance, Financial Transactions
Person-Based
Stake & Stock Ownership, Finance
4D Molecular Therapeutics News & Media
4D Molecular Therapeutics, Inc. (FDMT) Presents at Jefferies Global Healthcare Conference 2026 Transcript
4D Molecular Therapeutics, Inc. (FDMT) Jefferies Global Healthcare Conference 2026 June 3, 2026 3:10 PM EDTCompany ParticipantsDavid Kirn - Co-Founder,...4D Molecular Therapeutics, Inc. (FDMT) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript
4D Molecular Therapeutics, Inc. (FDMT) RBC Capital Markets Global Healthcare Conference 2026 May 19, 2026 2:35 PM EDTCompany ParticipantsChristopher Simms -...4D Molecular Therapeutics Inc (FDMT): Gene Therapy Stock Made for You?
4D Molecular Therapeutics Inc (NASDAQ:FDMT) is one of the best gene therapy stocks to buy in 2026. The stock has gained nearly 30% year-to-date and surged more than 190% over the past year. Looking ahead, analysts expect FDMT stock to almost triple in the next 12 months as the company continues to advance its clinical […]4D Molecular Therapeutics Touts Rapid Phase 3 Momentum for Retinal Gene Therapy
4D Molecular Therapeutics (NASDAQ:FDMT) executives said the company is seeing strong clinical trial momentum for its lead retinal gene therapy candidate, 4D-150, as it advances through late-stage development for wet age-related macular degeneration and prepares to begin a Phase 3 trial in diabetic m
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding 4D Molecular Therapeutics
Sign Up For FreeTo access detailed company insights
4D Molecular Therapeutics (4DMT) is a clinical-stage biopharmaceutical company focused on inventing and developing innovative products to unlock the full potential of genetic medicine for the treatment of large-market diseases. The company utilizes its proprietary vector discovery platform, Therapeutic Vector Evolution, to engineer customized gene... Read More
